| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Evotec AG | 30 | 3 | 2 | 1 | €23.03 | €28.00 | 21.581% |
| Pfizer Inc. | 19 | 2 | 4 | 0 | €32.30 | €38.00 | 17.647% |
| Johnson & Johnson | 17 | 1 | 4 | 0 | €122.48 | €140.15 | 14.427% |
| AbbVie Inc. | 14 | 1 | 1 | 1 | €71.10 | €96.31 | 35.451% |
| Morphosys AG | 15 | 3 | 0 | 2 | €88.20 | €130.00 | 47.392% |
| Novo Nordisk A/S | 12 | 1 | 0 | 0 | €59.75 | €65.50 | 9.623% |
| Bristol-Myers Squibb | 11 | 0 | 2 | 0 | €50.69 | €62.00 | 22.312% |
| Abbott Laboratories | 11 | 1 | 2 | 0 | €90.87 | €104.35 | 14.829% |
| Incyte Corp. | 11 | 1 | 0 | 1 | €75.62 | €110.70 | 46.388% |
| Canopy Growth Corp | 13 | 3 | 1 | 1 | €16.63 | €20.00 | 20.250% |
| Eli Lilly Corp. | 10 | 1 | 1 | 0 | €119.98 | €160.00 | 33.356% |
| Merck & Co. Inc. | 10 | 1 | 1 | 0 | €67.40 | €85.00 | 26.113% |
| Bausch Health Companies Inc. | 9 | 1 | 0 | 1 | €15.48 | €27.40 | 77.003% |
| Amgen Inc. | 9 | 1 | 0 | 0 | €191.40 | €227.50 | 18.861% |
| Epigenomics AG NA | 7 | 0 | 1 | 0 | €0.77 | €2.55 | 228.811% |
| Teva Pharmaceutical Industries Ltd ADR | 9 | 2 | 0 | 0 | €7.89 | €15.00 | 90.114% |
| BB Biotech AG | 7 | 0 | 0 | 0 | €59.00 | €73.95 | 25.339% |
| Sarepta Therapeutics | 8 | 1 | 1 | 0 | €116.52 | €160.00 | 37.315% |
| Dynavax Technologies Corp | 8 | 1 | 0 | 1 | €3.50 | €10.00 | 185.470% |
| Biogen Inc. | 9 | 3 | 0 | 0 | €223.45 | €270.00 | 20.832% |
| Vertex Pharmaceuticals Inc. | 7 | 1 | 2 | 0 | €178.30 | €270.00 | 51.430% |
| Alnylam Pharmace. | 7 | 1 | 0 | 0 | €111.04 | €140.00 | 26.081% |
| Sangamo Therapeutics Inc. | 7 | 1 | 0 | 1 | €9.15 | €14.49 | 58.435% |
| Paion AG | 8 | 2 | 1 | 1 | €2.39 | €4.00 | 67.364% |
| Acadia Pharmaceuticals | 7 | 1 | 0 | 0 | €35.71 | €55.00 | 54.040% |
